Cloud 9fin
Who watches the WeightWatchers?
Mar 21, 2024
The podcast discusses the impact of weight loss drugs on companies like Weight Watchers and Herbalife. It delves into financial challenges, subscriber losses, and the influence of GLP1s. The podcast also explores the role of Oprah Winfrey in these scenarios and the proactive creditor organization in distressed companies.
11:25
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- GLP-1 drugs impact Weight Watchers, prompting lenders' actions and stock increase.
- Herbalife faces challenges from GLP-1 drugs, investor meetings, and refinance concerns.
Deep dives
Effects of GLP-1 Drugs on Weight Watchers and Oprah Winfrey
The popularity of GLP-1 drugs like Ozempic and Wigovi has impacted Weight Watchers negatively, leading to subscriber losses, amplified by Oprah Winfrey's departure from the Weight Watchers board. This situation prompted Weight Watchers' lenders to engage a law firm to prepare for talks, causing a 13% stock increase. Weight Watchers is exploring options to improve leverage ratio and considering capital structure changes, with bonds quoted in the 40s.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
